Pre-clinical toxicology studies: Our lead product is a patent-protected, specific microRNA discovered at Baylor College of Medicine in Houston, TX, that acts as a central regulator of pancreatic cancer. We are able to synthesize and introduce this molecule into tumors, and have demonstrated that we can stop tumor growth and metastasis in vitro and in vivo.

Discovery phase: We are currently developing a number of additional microRNA, delivery, and diagnostic applications which are in the discovery and testing phase.